Free Trial

Allogene Therapeutics (ALLO) Institutional Ownership

Allogene Therapeutics logo
$1.46 0.00 (0.00%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$1.49 +0.03 (+2.05%)
As of 06:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Allogene Therapeutics (NASDAQ:ALLO)

Current
Institutional Ownership
Percentage
83.63%
Number of
Institutional Buyers
(last 12 months)
83
Total
Institutional Inflows
(last 12 months)
$187.47M
Number of
Institutional Sellers
(last 12 months)
32
Total
Institutional Outflows
(last 12 months)
$25.31M
Get ALLO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Allogene Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ALLO Institutional Buying and Selling by Quarter

Allogene Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026WINTON GROUP Ltd158,160$329K0.0%+30.5%0.046%
9/9/2026Engineers Gate Manager LP98,511$205K0.0%-7.0%0.029%
9/9/2026Squarepoint Ops LLC241,524$502K0.0%+107.5%0.070%
8/27/2026Corient Private Wealth LP41,100$85K0.0%N/A0.012%
8/23/2026Frazier Life Sciences Management L.P.22,446,668$46.69M1.0%+491.2%6.497%
8/21/2026AXQ Capital LP83,217$173K0.0%+12.6%0.024%
8/20/2026Headlands Technologies LLC205,453$427K0.0%-22.7%0.059%
8/20/2026GTS Securities LLC13,220$27K0.0%N/A0.004%
8/18/2026Coastal Bridge Advisors LLC21,789$45K0.0%N/A0.006%
8/18/2026Public Employees Retirement System of Ohio266,417$554K0.0%N/A0.077%
8/17/2026Corient Private Wealth LP40,793$85K0.0%N/A0.012%
8/17/2026Bank of America Corp DE3,187,320$6.63M0.0%N/A0.923%
8/15/2026Man Group plc701,901$1.46M0.0%N/A0.203%
8/14/2026Hsbc Holdings PLC259,747$557K0.0%N/A0.075%
8/14/2026Primecap Management Co. CA13,123,440$27.30M0.0%N/A3.802%
8/14/2026Canada Pension Plan Investment Board115,500$240K0.0%N/A0.033%
8/14/2026Legal & General Group Plc25,743$54K0.0%N/A0.007%
8/14/2026The Manufacturers Life Insurance Company426,274$887K0.0%N/A0.124%
8/14/2026Partners Capital Investment Group LLP161,597$336K0.0%N/A0.047%
8/14/2026Algert Global LLC122,420$255K0.0%-73.6%0.035%
8/13/2026Connor Clark & Lunn Investment Management Ltd.322,827$671K0.0%N/A0.094%
8/13/2026Bank of Nova Scotia97,400$203K0.0%N/A0.028%
8/12/2026Quantbot Technologies LP116,933$243K0.0%N/A0.034%
8/12/2026Ieq Capital LLC580,371$1.21M0.0%N/A0.168%
8/11/2026E Fund Management Co. Ltd.47,593$99K0.0%N/A0.014%
8/7/2026BlackRock Inc.30,146,963$62.71M0.0%N/A8.734%
8/7/2026Pallas Capital Advisors LLC11,844$25K0.0%N/A0.003%
8/7/2026Deutsche Bank AG281,949$586K0.0%N/A0.082%
8/7/2026Mitsubishi UFJ Asset Management Co. Ltd.547,189$1.14M0.0%N/A0.159%
8/6/2026Bank of New York Mellon Corp727,182$1.51M0.0%N/A0.211%
8/6/2026State of Wyoming33,840$70K0.0%N/A0.010%
8/6/2026GSA Capital Partners LLP285,590$594K0.0%N/A0.083%
8/3/2026Walleye Capital LLC3,268,012$6.80M0.0%N/A0.947%
7/9/2026Hennion & Walsh Asset Management Inc.722,928$1.50M0.0%N/A0.209%
7/8/2026Westmount Partners LLC36,000$75K0.0%N/A0.010%
5/21/2026Essential Partners LLC19,410$47K0.0%+525.9%0.008%
5/19/2026Bank of America Corp DE2,134,473$5.21M0.0%+111.9%0.872%
5/19/2026Bull Harbor Capital LLC12,703$31K0.0%N/A0.005%
5/18/2026Royal Bank of Canada56,532$138K0.0%+15.9%0.023%
5/16/2026The Manufacturers Life Insurance Company654,180$1.60M0.0%+35.0%0.267%
Why major institutions are piling into this digital asset now (Ad)

BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel

Get the name, the ticker, and exactly how to buy it
5/14/2026Renaissance Technologies LLC2,139,328$5.22M0.0%-2.2%0.874%
5/14/2026Public Employees Retirement System of Ohio177,875$434K0.0%N/A0.073%
5/7/2026Dimensional Fund Advisors LP1,201,655$2.93M0.0%+25.5%0.491%
5/5/2026Bank of New York Mellon Corp395,187$964K0.0%-2.6%0.161%
5/1/2026Candriam S.C.A.2,997,318$7.31M0.0%+30.0%1.224%
4/30/2026Hsbc Holdings PLC260,404$638K0.0%+75.8%0.106%
4/30/2026Harold Davidson & Associates Inc.289,222$706K0.3%+48.5%0.118%
4/29/2026R Squared Ltd45,245$110K0.1%-47.5%0.018%
4/28/2026Abel Hall LLC26,647$65K0.0%+56.4%0.011%
4/20/2026Kestra Private Wealth Services LLC10,909$27K0.0%N/A0.004%
4/17/2026Krilogy Financial LLC16,780$40K0.0%N/A0.007%
4/16/2026SG Americas Securities LLC15,390$38K0.0%-35.8%0.006%
3/20/2026Hsbc Holdings PLC148,136$199K0.0%+57.5%0.061%
3/3/2026Caitong International Asset Management Co. Ltd44,334$61K0.0%+84.4%0.020%
2/23/2026Virtu Financial LLC42,351$58K0.0%+55.9%0.019%
2/19/2026Invesco Ltd.609,807$835K0.0%+16.1%0.271%
2/18/2026Mercer Global Advisors Inc. ADV29,512$40K0.0%+23.0%0.013%
2/18/2026XTX Topco Ltd476,307$653K0.0%-38.5%0.212%
2/18/2026Zacks Investment Management192,731$264K0.0%-63.4%0.086%
2/18/2026Virtus Investment Advisers LLC176,178$241K0.1%+116.8%0.078%
2/18/2026Quadrature Capital Ltd274,416$376K0.0%+15.3%0.122%
2/18/2026Millennium Management LLC1,841,307$2.52M0.0%-45.7%0.819%
2/18/2026Man Group plc526,106$721K0.0%+86.5%0.234%
2/17/2026AQR Capital Management LLC1,429,247$1.96M0.0%-22.9%0.636%
2/17/2026Price T Rowe Associates Inc. MD3,209,275$4.40M0.0%-12.7%1.428%
2/17/2026Russell Investments Group Ltd.40,041$55K0.0%+83.3%0.018%
2/17/2026Captrust Financial Advisors53,101$73K0.0%+237.9%0.024%
2/17/2026Royal Bank of Canada48,794$67K0.0%-95.6%0.022%
2/17/2026Graham Capital Management L.P.148,671$204K0.0%-24.7%0.066%
2/16/2026Squarepoint Ops LLC104,656$143K0.0%-61.0%0.047%
2/16/2026Barclays PLC642,687$880K0.0%+7.3%0.286%
2/13/2026Marshall Wace LLP285,561$391K0.0%N/A0.127%
2/13/2026CANADA LIFE ASSURANCE Co50,951$69K0.0%+28.2%0.023%
2/13/2026Kalehua Capital Management LLC2,546,129$3.49M3.2%N/A1.133%
2/13/2026Smartleaf Asset Management LLC28,927$38K0.0%N/A0.013%
2/13/2026Headlands Technologies LLC46,778$64K0.0%-66.6%0.021%
2/13/2026OpenArc Corporate Advisory LLC162,984$223K0.0%N/A0.073%
2/13/2026Charles Schwab Investment Management Inc.1,355,809$1.86M0.0%+16.4%0.603%
2/13/2026State Street Corp2,761,400$3.78M0.0%+0.2%1.229%
2/13/2026Ieq Capital LLC435,267$596K0.0%+15.7%0.194%
2/13/2026Wells Fargo & Company MN200,276$274K0.0%+38.3%0.089%
2/12/2026HRT Financial LP72,751$99K0.0%-45.1%0.032%
2/12/2026MetLife Investment Management LLC34,823$48K0.0%-39.2%0.015%
2/12/2026Renaissance Technologies LLC2,187,084$3.00M0.0%-24.4%0.973%
2/12/2026Dimensional Fund Advisors LP957,816$1.31M0.0%-54.2%0.426%
2/12/2026Patient Square Capital LP4,963,756$6.80M1.5%+66.5%2.209%
2/11/2026Primecap Management Co. CA8,139,840$11.15M0.0%+15.0%3.622%
2/11/2026Deutsche Bank AG131,086$180K0.0%-6.9%0.058%
2/11/2026Cerity Partners LLC97,909$134K0.0%-79.0%0.044%
2/11/2026LPL Financial LLC170,750$234K0.0%-3.8%0.076%
Federal Reserve Reveals Disturbing New Plan To Control Your Money (Ad)

A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.tc pixel

Click here to see the document and learn protective steps
2/11/2026Harold Davidson & Associates Inc.194,753$267K0.1%-34.1%0.087%
2/10/2026Goldman Sachs Group Inc.2,289,458$3.14M0.0%+90.2%1.019%
2/10/2026Intech Investment Management LLC86,637$119K0.0%+20.5%0.039%
2/9/2026Geode Capital Management LLC3,932,910$5.39M0.0%+2.6%1.750%
2/6/2026GSA Capital Partners LLP613,998$841K0.1%+235.7%0.273%
2/5/2026Navalign LLC49,398$68K0.0%-17.5%0.022%
1/30/2026R Squared Ltd86,215$118K0.1%+40.5%0.038%
1/23/2026Choreo LLC38,849$51K0.0%N/A0.017%
1/16/2026Aberdeen Group plc2,086,332$2.86M0.0%+31.9%0.928%
1/1/2026JPMorgan Chase & Co.908,725$1.13M0.0%-2.7%0.404%


ALLO Institutional Ownership - Frequently Asked Questions

During the previous two years, 150 institutional investors and hedge funds held shares of Allogene Therapeutics. The most heavily invested institutionals were FMR LLC ($84.08M), BlackRock Inc. ($62.71M), Frazier Life Sciences Management L.P. ($46.69M), Primecap Management Co. CA ($27.30M), Vanguard Group Inc. ($11.19M), Candriam S.C.A. ($7.31M), and Patient Square Capital LP ($6.80M).Learn more on Allogene Therapeutics' institutional investors.

83.63% of Allogene Therapeutics' stock is owned by institutional investors. Learn more on ALLO's institutional investor holdings.

Of the 131 institutional investors that purchased Allogene Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($30.15M), Frazier Life Sciences Management L.P. ($19.65M), Primecap Management Co. CA ($16.33M), Bank of America Corp DE ($4.93M), Goldman Sachs Group Inc. ($4.83M), Lynx1 Capital Management LP ($4.67M), and Patient Square Capital LP ($4.09M).

Institutional investors have bought a total of 97,192,640 shares in the last 24 months. This purchase volume represents approximately $187.47M in transactions.

Of the 32 institutional investors that sold Allogene Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Lynx1 Capital Management LP ($10.51M), Dimensional Fund Advisors LP ($1.78M), Millennium Management LLC ($1.55M), Royal Bank of Canada ($1.05M), Renaissance Technologies LLC ($754.48K), Price T Rowe Associates Inc. MD ($468.20K), and AQR Capital Management LLC ($424.31K).

Institutional investors have sold a total of 19,311,243 shares in the last 24 months. This volume of shares sold represents approximately $25.31M in transactions.



Institutional ownership data for NASDAQ:ALLO is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners